Take this short 5-question quiz to find out what you know--or, what you may have missed--about the latest developments in COPD.
Machine Learning Model Effectively Predicts Depression Risk in Adults with COPD
The model demonstrated 70.63% accuracy for predicting depression, a common comorbidity seen in COPD and one that increases risk for negative outcomes.
AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma
The KALOS and LOGOS registration trials in patients with uncontrolled asthma compared the triple fixed dose BGF with dual combination therapy.
New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases
New clinical trial findings to be presented at ATS 2025 highlights the effectiveness of dupilumab in treating COPD and asthma.
Mepolizumab Reduces AER in COPD Leading to Emergency Care by 35%: MATINEE Findings Published in NEJM
Mepolizumab also cut annualized exacerbation rates by 21% across the full study cohort and by 31% in a subgroup of participants with chronic bronchitis only.
Perceived Stress Tied to Worsened Respiratory Outcomes, Decreased QoL in Adults with COPD
Researchers reported higher levels of perceived stress were associated with worse respiratory outcomes, particularly among individuals with severe COPD.
Untreated Depression, Anxiety Worsen COPD Outcomes: Daily Dose
Your daily dose of the clinical news you may have missed.